این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
Acta Medica Iranica، جلد ۵۷، شماره ۲، صفحات ۸۳-۹۳
عنوان فارسی
چکیده فارسی مقاله
کلیدواژه‌های فارسی مقاله
عنوان انگلیسی siRNA Delivery Technology for Cancer Therapy: Promise and Challenges
چکیده انگلیسی مقاله Small interfering RNAs (siRNA) technology has shown great promise as a new class of therapeutic interventions for the treatment of cancer and other diseases. It is a remarkable endogenous pathway that can regulate sequence-specific gene silencing. Despite the excitement about possible applications of this biological process for sequence-specific gene regulation, the major limitations against the use of siRNA-based therapeutics are their rapid degradation by serum nuclease, poor cellular uptake, and rapid renal clearance following systemic delivery, off-target effects and the induction of immune responses. Many researchers have tried to overcome these limitations by developing nuclease-resistant chemically-modified siRNAs and a variety of synthetic and natural biodegradable lipids and polymers to enhance the efficacy and safety profiles of siRNA delivery. Ideal siRNA-based delivery systems for cancer therapy must be clinically suitable, safe and effective. In this review, we introduce the greatest challenges in achieving efficient RNAi delivery and discuss design criteria and various delivery strategies for cancer therapy, including chemical modifications, lipid-based nano-vectors, polymer-mediated delivery systems, conjugate delivery systems, and others.
کلیدواژه‌های انگلیسی مقاله
نویسندگان مقاله | Fateme Karimi Dermani
Department of Molecular Medicine, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.


| Farid Azizi Jalilian
Department of Medical Microbiology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.


| Hossein Hossienkhani
Innovation Center for Advanced Technology, Matrix, Inc., New York, NY 10029, USA.


| Razieh Ezati
Institute of Medical Biotechnology, National Institute of Genetic Engineering and Biotechnology, Tehran, Iran.


| Razieh Amini
Department of Molecular Medicine, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran. AND Molecular Medicine Research Center, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.
نشانی اینترنتی http://acta.tums.ac.ir/index.php/acta/article/view/7146
فایل مقاله اشکال در دسترسی به فایل - ./files/site1/rds_journals/56/article-56-1353215.pdf
کد مقاله (doi)
زبان مقاله منتشر شده
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده
برگشت به: صفحه اول پایگاه   |   نسخه مرتبط   |   نشریه مرتبط   |   فهرست نشریات